Advanced Research Consultants

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease2 trials

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Completed2 trials

Lead sponsor

• Alzheon Inc.1 trial
• Eli Lilly and Company1 trial

Closed trials

• Completed

  An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects

  NCT04770220· Phase 3· Alzheon Inc.· Source

• Completed

  A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)

  NCT04640077· Phase 2· Eli Lilly and Company· Source